Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data
| dc.contributor.author | Ojal J | |
| dc.contributor.author | Flasche S | |
| dc.contributor.author | Hammitt LL | |
| dc.contributor.author | Akech D | |
| dc.contributor.author | Kiti MC | |
| dc.contributor.author | Kamau T | |
| dc.contributor.author | Adetifa I | |
| dc.contributor.author | Nurhonen M | |
| dc.contributor.author | Scott JAG | |
| dc.contributor.author | Auranen K | |
| dc.contributor.organization | fi=tilastotiede|en=Statistics| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.42133013740 | |
| dc.converis.publication-id | 27628433 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/27628433 | |
| dc.date.accessioned | 2022-10-27T12:17:02Z | |
| dc.date.available | 2022-10-27T12:17:02Z | |
| dc.description.abstract | Background: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a catch-up campaign for children aged <5 years in Kilifi County. In a post-vaccination surveillance study based in Kilifi, there was a substantial decline in invasive pneumococcal disease (IPD). However, given the continued circulation of the vaccine serotypes, it is possible that vaccine-serotype disease may re-emerge once the effects of the catch-up campaign wear off.Methods: We developed, a compartmental, age-structured dynamic model of pneumococcal carriage and invasive disease for three serotype groups: the 10-valent vaccine serotypes and two groups of non vaccine serotypes based on their susceptibility to mutual competition. The model was calibrated to age- and serotype-specific data on carriage and IPD in the pre-vaccination era and used to predict carriage prevalence and IPD up to ten years post-vaccination in Kilifi. The model was validated against the observed carriage prevalence after vaccine introduction.Results: The model predicts a sustained reduction in vaccine-type pneumococcal carriage prevalence from 33% to 8% in infants and from 30% to 8% in 1-5 year olds over the 10-year period following vaccine introduction. The incidence of IPD is predicted to decline across all age groups resulting in an overall reduction of 56% in the population, corresponding to 10.4 cases per 100,000 per year. The vaccine-type IPD incidence is estimated to decline by 83% while non-vaccine-type IPD incidence is predicted to increase by 52%. The model's predictions of carriage prevalence agrees well with the observed data in the first five years post-vaccination.Conclusion: We predict a sustained and substantial decline in IPD through PCV vaccination and that the current regimen is insufficient to fully eliminate vaccine-serotype circulation in the model. We show that the observed impact is likely to be sustained despite waning effects of the catch-up campaign. (C) 2017 The Author(s). Published by Elsevier Ltd. | |
| dc.format.pagerange | 4561 | |
| dc.format.pagerange | 4568 | |
| dc.identifier.jour-issn | 0264-410X | |
| dc.identifier.olddbid | 174440 | |
| dc.identifier.oldhandle | 10024/157534 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/34328 | |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0264410X17309155?via=ihub | |
| dc.identifier.urn | URN:NBN:fi-fe2021042717561 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Auranen, Kari | |
| dc.okm.discipline | 112 Statistics and probability | en_GB |
| dc.okm.discipline | 3111 Biomedicine | en_GB |
| dc.okm.discipline | 3121 Internal medicine | en_GB |
| dc.okm.discipline | 112 Tilastotiede | fi_FI |
| dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
| dc.okm.discipline | 3121 Sisätaudit | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | ELSEVIER SCI LTD | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.doi | 10.1016/j.vaccine.2017.07.019 | |
| dc.relation.ispartofjournal | Vaccine | |
| dc.relation.issue | 35 | |
| dc.relation.volume | 35 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/157534 | |
| dc.title | Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data | |
| dc.year.issued | 2017 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- 1-s2.0-S0264410X17309155-main.pdf
- Size:
- 1.27 MB
- Format:
- Adobe Portable Document Format
- Description:
- Publisher's PDF